Products for Research Use Only
RegisterLogin

Domatinostat

CAT: 0804-HY-16012A-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-16012A-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Domatinostat (4SC-202 free base) is a selective class I HDAC inhibitor with IC50 of 1.20 μM, 1.12 μM, and 0.57 μM for HDAC1, HDAC2, and HDAC3, respectively. It also displays inhibitory activity against Lysine specific demethylase 1 (LSD1) .
CAS Number
910462-43-0
Product Name Alternative
4SC-202 (free base)
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; HDAC
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/4SC-202-free-base.html
Purity
99.34
Solubility
DMSO : ≥ 58 mg/mL
Smiles
O=C(NC1=CC=CC=C1N)/C=C/C2=CN(S(=O)(C3=CC=C(C4=CN(C)N=C4)C=C3)=O)C=C2
Molecular Formula
C23H21N5O3S
Molecular Weight
447.51
Precautions
H302, H315, H319, H335
References & Citations
[1]Pinkerneil M, et al. Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines. Target Oncol. 2016 Dec;11 (6) :783-798.|[2]Zhijun H, et al. Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells. Tumour Biol. 2016 Aug;37 (8) :10257-67.|[3]Fu M, et al. 4SC-202 activates ASK1-dependent mitochondrial apoptosis pathway to inhibit hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2016 Mar 4;471 (2) :267-73|[4]S.W.Henning, et al. Preclinical characterization of 4SC-202, a noval isotype specific HDAC inhibitor.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC5; HDAC9
Citation 01
J Mol Med (Berl) . 2019 Aug;97 (8) :1183-1193.|Proc Natl Acad Sci U S A. 2019 Feb 19;116 (8) :2961-2966. |Am J Transl Res. 2020 Jun 15;12 (6) :2968-2983.

Alternative Products

CatalogName
T6362-01Domatinostat
MBS3845421-01Domatinostat tosylate
A20986-5Domatinostat tosylate 5mg
C12777-10mM/1mLDomatinostat (4SC-202)
A20986-10Domatinostat tosylate 10mg
A20986-100Domatinostat tosylate 100mg
A20986-50Domatinostat tosylate 50mg
A20986-25Domatinostat tosylate 25mg
A20986-1Domatinostat tosylate 1mg

Popular Products